Evidence map›Paper›PMID 40526805›Full record

ArticleG3 (Bethesda, Md.)2025

Parental origin of transgene determines recombination efficiency in GFAP-creERT2 mice.

Karmen Mah, Adam Roszczyk, Ashley E Frakes

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Karmen MahGenetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20892, USA.
Adam RoszczykGenetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20892, USA.
Ashley E FrakesGenetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-8424-0770

Funding

Glial regulation of ER stress resistanceZIADK075172 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI FRAKES, ASHLEY · 2022 to 2025
$11.7M
Frakes LabIntramural NIH HHS ZIA DK075172NIDDK Intramural Research Program 1ZIADK075172-03
6 · The paper itself

Abstract

The Cre-loxP system is a powerful tool for spatial and temporal genetic manipulations. However, the system is prone to several limitations and caveats with respect to variable expression and recombination in unintended cell types. Using one of the most widely used astrocyte Cre lines, hGFAP-creERT2 ((GFAP-cre/ERT2)505Fmv/J), we found that parental origin of the hGFAP-creERT2 transgene is a determinant of recombination efficiency. Recombination was robust in animals with paternally inherited hGFAP-creERT2. However, animals with maternally inherited Cre exhibited little to no recombination. This result was recapitulated using female hGFAP-creERT2 mice procured directly from Jackson Laboratory. We did not observe transgenerational suppression of Cre recombination in maternally inherited hGFAP-CreERT2. These data highlight the need for careful planning and documentation of breeding schemes when working with Cre mice.

Indexed as

IntegrasesRecombination, GeneticTransgenesAnimalsFemaleMaleMiceMice, TransgenicCre recombinaseIntegrasesastrocytesCreCreERT2inheritancematernalmiceneurosciencerecombination

Identifiers

PMID40526805
PMCPMC12341896

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.